Rho Ventures IV-A, L.P.

CIK 1632862 · last filed 2015-11-18

Rho Ventures IV-A, L.P. is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2015. The most recent filing, for ITEK, was dated Nov 18, 2015. The firm reports its address in New York, NY. 3 SEC filings were submitted jointly with Rho Ventures IV Holdings LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

Companies

Total Filings

Lifetime Open-Market Net

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

ITEK price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Exposure by company

latest

OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address

152 WEST 57TH STREET
23RD FLOOR
NEW YORK, NY 10019

Phone

(212) 751-6677

State of Incorporation

Related Filers

Rho Ventures IV Holdings LLC — 3 joint filings, latest 2015-11-18

Habib Kairouz — 2 joint filings, latest 2015-02-25

Mark Leschly — 2 joint filings, latest 2015-02-25

RHO MANAGEMENT VENTURES IV LLC — 2 joint filings, latest 2015-02-25

RHO VENTURES IV GMBH & CO BETEILIGUNGS KG — 2 joint filings, latest 2015-02-25

RHO VENTURES IV LP — 2 joint filings, latest 2015-02-25

RHO VENTURES IV QP LP — 2 joint filings, latest 2015-02-25

Joshua Ruch — 2 joint filings, latest 2015-02-25

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
ROCKET PHARMACEUTICALS, INC. (ITEK) Delisted	10%+ Owner	159,124	—	—	$0	1	2015-11-18

Recent Filings

1 filing

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2015-11-18	ROCKET PHARMACEUTICALS, INC. (ITEK) Delisted	Other (J)	−485,588	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.